Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2012, Article ID 436174, 6 pages
http://dx.doi.org/10.1155/2012/436174
Clinical Study

Effect of a Selective Progesterone Receptor Modulator on Induction of Apoptosis in Uterine Fibroids In Vivo

1Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague, Apolinarska 18, 128 00 Prague, Czech Republic
2Institute of Pathology, First Faculty of Medicine, Charles University in Prague, 128 00 Prague, Czech Republic
3Department of Obstetrics and Gynaecology, University Hospital Brno, 625 00 Brno, Czech Republic
4Department of Obstetrics and Gynaecology, Second Faculty of Medicine, Charles University in Prague, 150 06 Prague, Czech Republic

Received 7 March 2012; Revised 18 May 2012; Accepted 18 May 2012

Academic Editor: Faustino R. Pérez-López

Copyright © 2012 Petr Horak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. E. Wallach and N. F. Vlahos, “Uterine myomas: an overview of development, clinical features, and management,” Obstetrics and Gynecology, vol. 104, no. 2, pp. 393–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Arici and I. Sozen, “Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-β1 in human myometrium and leiomyoma,” American Journal of Obstetrics and Gynecology, vol. 188, no. 1, pp. 76–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Marshall, D. Spiegelman, R. L. Barbieri et al., “Variation in the incidence of uterine leiomyoma among premenopausal women by age and race,” Obstetrics and Gynecology, vol. 90, no. 6, pp. 967–973, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Maruo, H. Matsuo, Y. Shimomura et al., “Effects of progesterone on growth factor expression in human uterine leiomyoma,” Steroids, vol. 68, no. 10–13, pp. 817–824, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Sozen and A. Arici, “Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors,” Obstetrics and Gynecology Clinics of North America, vol. 33, no. 1, pp. 41–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Toro, M. L. Nickerson, M. H. Wei et al., “Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America,” American Journal of Human Genetics, vol. 73, no. 1, pp. 95–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. C. L. Walker, “Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma,” Recent Progress in Hormone Research, vol. 57, pp. 277–294, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. K. Nieman, W. Blocker, T. Nansel et al., “Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study,” Fertility and Sterility, vol. 95, no. 2, pp. 767.e2–772.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Wilkens, K. Chwalisz, C. Han et al., “Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 12, pp. 4664–4671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Chen, N. Ohara, J. Wang et al., “A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1296–1304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Donnez, T. F. Tatarchuk, and P. Bouchard, “Ulipristal acetate versus placebo for fibroid treatment prior to surgery,” The New England Journal of Medicine, vol. 366, no. 5, pp. 409–420, 2012. View at Publisher · View at Google Scholar
  12. J. M. Higham, P. M. S. O'Brien, and R. W. Shaw, “Assessment of menstrual blood loss using a pictorial chart,” British Journal of Obstetrics and Gynaecology, vol. 97, no. 8, pp. 734–739, 1990. View at Google Scholar · View at Scopus
  13. C. A. H. Janssen, P. C. Scholten, and A. P. M. Heintz, “A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss,” Obstetrics and Gynecology, vol. 85, no. 6, pp. 977–982, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. K. D. Burroughs, R. Fuchs-Young, B. Davis, and C. L. Walker, “Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat,” Biology of Reproduction, vol. 63, no. 5, pp. 1322–1330, 2000. View at Google Scholar · View at Scopus
  15. K. N. Khan, M. Kitajima, K. Hiraki et al., “Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy,” Human Reproduction, vol. 25, no. 3, pp. 642–653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. W. M. Liu, “Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic leiomyomas,” Journal of the American Association of Gynecologic Laparoscopists, vol. 7, no. 1, pp. 125–129, 2000. View at Google Scholar · View at Scopus
  17. J. H. Ravina, D. Herbreteau, N. Ciraru-Vigneron et al., “Arterial embolisation to treat uterine myomata,” The Lancet, vol. 346, no. 8976, pp. 671–672, 1995. View at Google Scholar · View at Scopus
  18. C. Recaldini, G. Carrafiello, D. Laganà et al., “Percutaneous sonographically guided radiofrequency ablation of medium-sized fibroids: feasibility study,” American Journal of Roentgenology, vol. 189, no. 6, pp. 1303–1306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. A. Stewart, W. M. W. Gedroyc, C. M. C. Tempany et al., “Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique,” American Journal of Obstetrics and Gynecology, vol. 189, no. 1, pp. 48–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Eisinger, S. Meldrum, K. Fiscella, H. D. Le Roux, and D. S. Guzick, “Low-dose mifepristone for uterine leiomyomata,” Obstetrics and Gynecology, vol. 101, no. 2, pp. 243–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Chegini, C. Ma, X. M. Tang, and R. S. Williams, “Effects of GnRH analogues, “add-back” steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-β expression,” Molecular Human Reproduction, vol. 8, no. 12, pp. 1071–1078, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Maruo, N. Ohara, H. Matsuo et al., “Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas,” Contraception, vol. 75, no. 6, pp. S99–S103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. L. Olive, S. R. Lindheim, and E. A. Pritts, “Non-surgical management of leiomyoma: impact on fertility,” Current Opinion in Obstetrics and Gynecology, vol. 16, no. 3, pp. 239–243, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B. W. Rackow and A. Arici, “Options for medical treatment of myomas,” Obstetrics and Gynecology Clinics of North America, vol. 33, no. 1, pp. 97–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shozu, K. Murakami, T. Segawa, T. Kasai, and M. Inoue, “Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor,” Fertility and Sterility, vol. 79, no. 3, pp. 628–631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. V. De Leo, G. Morgante, A. La Marca et al., “A benefit-risk assessment of medical treatment for uterine leiomyomas,” Drug Safety, vol. 25, no. 11, pp. 759–779, 2002. View at Google Scholar · View at Scopus
  27. A. Golan, I. Bukovsky, M. Pansky, D. Schneider, Z. Weinraub, and E. Caspi, “Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata,” Human Reproduction, vol. 8, no. 3, pp. 450–452, 1993. View at Google Scholar · View at Scopus
  28. A. Lethaby, B. Vollenhoven, and M. Sowter, “Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review,” An International Journal of Obstetrics and Gynaecology, vol. 109, no. 10, pp. 1097–1108, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Manyonda, E. Sinthamoney, and A. M. Belli, “Controversies and challenges in the modern management of uterine fibroids,” An International Journal of Obstetrics and Gynaecology, vol. 111, no. 2, pp. 95–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Fujimoto, S. Ichigo, M. Hori, M. Nishigaki, and T. Tamaya, “Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors,” Tumor Biology, vol. 16, no. 4, pp. 254–260, 1995. View at Google Scholar · View at Scopus
  31. S. Chrapusta, W. Sieinski, B. Konopka, J. Szamborski, and Z. Paszko, “Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumour histology and the phase of menstrual cycle,” European Journal of Gynaecological Oncology, vol. 11, no. 5, pp. 381–387, 1990. View at Google Scholar · View at Scopus
  32. K. Kawaguchi, S. Fujii, I. Konishi, Y. Nanbu, H. Nonogaki, and T. Mori, “Mitotic activity in uterine leiomyomas during the menstrual cycle,” American Journal of Obstetrics and Gynecology, vol. 160, no. 3, pp. 637–641, 1989. View at Google Scholar · View at Scopus
  33. D. DeManno, W. Elger, R. Garg et al., “Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy,” Steroids, vol. 68, no. 10–13, pp. 1019–1032, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Murphy, A. J. Morales, L. M. Kettel, and S. S. C. Yen, “Regression of uterine leiomyomata to the antiprogesterone RU486: dose- response effect,” Fertility and Sterility, vol. 64, no. 1, pp. 187–190, 1995. View at Google Scholar · View at Scopus
  35. M. Bagaria, A. Suneja, N. B. Vaid, K. Guleria, and K. Mishra, “Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 49, no. 1, pp. 77–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Wilkens, A. R. W. Williams, K. Chwalisz, C. Han, I. T. Cameron, and H. O. D. Critchley, “Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN,” Human Reproduction, vol. 24, no. 5, pp. 1036–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. R. W. Williams, H. O. D. Critchley, J. Osei et al., “The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata,” Human Reproduction, vol. 22, no. 6, pp. 1696–1704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Maruo, N. Ohara, S. Yoshida et al., “Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system,” Contraception, vol. 82, no. 5, pp. 435–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Yin, Z. Lin, Y. H. Cheng et al., “Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4459–4466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Yoshida, N. Ohara, Q. Xu et al., “Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth,” Seminars in Reproductive Medicine, vol. 28, no. 3, pp. 260–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. M. Martel, A. C. Ko, G. M. Christman, and J. M. Stribley, “Apoptosis in human uterine leiomyomas,” Seminars in Reproductive Medicine, vol. 22, no. 2, pp. 91–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. W. R. Duan, D. S. Gamer, S. D. Williams, C. L. Funckes-Shippy, I. S. Spath, and E. A. G. Blomme, “Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts,” Journal of Pathology, vol. 199, no. 2, pp. 221–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Donnez, J. Tomaszewski, and F. Vázquez, “PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids,” The New England Journal of Medicine, vol. 366, pp. 421–432, 2012. View at Google Scholar
  44. Committee on Gynecologic Practice, American College of Obstetricians, and Gynecologists: ACOG Committee Opinion, “Uterine artery embolization,” Obstetrics & Gynecology, vol. 103, pp. 403–404, 2004. View at Google Scholar
  45. D. Kuzel, M. Mara, P. Horak et al., “Comparative outcomes of hysteroscopic examinations performed after uterine artery embolization or laparoscopic uterine artery occlusion to treat leiomyomas,” Fertility and Sterility, vol. 95, no. 6, pp. 2143–2145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Homer and E. Saridogan, “Uterine artery embolization for fibroids is associated with an increased risk of miscarriage,” Fertility and Sterility, vol. 94, no. 1, pp. 324–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. K. H. Park, J. Y. Kim, J. S. Shin et al., “Treatment outcomes of uterine artery embolization and laparoscopic uterine artery ligation for uterine myoma,” Yonsei Medical Journal, vol. 44, no. 4, pp. 694–702, 2003. View at Google Scholar · View at Scopus